AU1072801A - Gel-forming compositions - Google Patents

Gel-forming compositions

Info

Publication number
AU1072801A
AU1072801A AU10728/01A AU1072801A AU1072801A AU 1072801 A AU1072801 A AU 1072801A AU 10728/01 A AU10728/01 A AU 10728/01A AU 1072801 A AU1072801 A AU 1072801A AU 1072801 A AU1072801 A AU 1072801A
Authority
AU
Australia
Prior art keywords
gel
forming compositions
compositions
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10728/01A
Inventor
L. Daniel Browne
Michael D. Dake
Jacob Waugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revance Therapeuticals Inc
Original Assignee
Essentia Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essentia Biosystems Inc filed Critical Essentia Biosystems Inc
Publication of AU1072801A publication Critical patent/AU1072801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AU10728/01A 1999-10-01 2000-10-02 Gel-forming compositions Abandoned AU1072801A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15736599P 1999-10-01 1999-10-01
US60157365 1999-10-01
US67556600A 2000-09-29 2000-09-29
US09675566 2000-09-29
PCT/US2000/027186 WO2001024775A1 (en) 1999-10-01 2000-10-02 Gel-forming compositions

Publications (1)

Publication Number Publication Date
AU1072801A true AU1072801A (en) 2001-05-10

Family

ID=26854060

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10728/01A Abandoned AU1072801A (en) 1999-10-01 2000-10-02 Gel-forming compositions

Country Status (2)

Country Link
AU (1) AU1072801A (en)
WO (1) WO2001024775A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001263281A1 (en) * 2000-05-18 2001-11-26 Genetix Pharmaceuticals, Inc. Polyethylene glycol (peg) polymers for the promotion of angiogenesis
WO2003060142A2 (en) * 2001-10-18 2003-07-24 Essentia Biosystems, Inc. Compositions and methods for controlled release
US7361368B2 (en) 2002-06-28 2008-04-22 Advanced Cardiovascular Systems, Inc. Device and method for combining a treatment agent and a gel
DE602005015872D1 (en) 2004-07-15 2009-09-17 Gynaecologiq B V COMPOSITION AND METHOD FOR THE MEDICAL IMAGE DISPLAY OF BODIES
US7854944B2 (en) 2004-12-17 2010-12-21 Advanced Cardiovascular Systems, Inc. Tissue regeneration
US20080125745A1 (en) 2005-04-19 2008-05-29 Shubhayu Basu Methods and compositions for treating post-cardial infarction damage
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US8303972B2 (en) 2005-04-19 2012-11-06 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9539410B2 (en) 2005-04-19 2017-01-10 Abbott Cardiovascular Systems Inc. Methods and compositions for treating post-cardial infarction damage
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
US9242005B1 (en) 2006-08-21 2016-01-26 Abbott Cardiovascular Systems Inc. Pro-healing agent formulation compositions, methods and treatments
US9005672B2 (en) 2006-11-17 2015-04-14 Abbott Cardiovascular Systems Inc. Methods of modifying myocardial infarction expansion
KR101674492B1 (en) 2008-03-31 2016-11-09 닛토덴코 가부시키가이샤 Permeant delivery system and methods for use thereof
NL2003660C2 (en) 2009-10-16 2011-04-19 Giskit B V Composition and method for medical imaging of body cavities.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86022A1 (en) * 1985-07-25 1987-02-04 Cird POLYCYLIC AROMATIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THE PHARMACEUTICAL AND COSMETIC FIELDS
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders
US5895801A (en) * 1997-03-31 1999-04-20 Avery Dennison Corporation Pressure-sensitive adhesives for marking films

Also Published As

Publication number Publication date
WO2001024775A9 (en) 2002-12-05
WO2001024775A1 (en) 2001-04-12

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU5271300A (en) Radiopaque compositions
AU2115301A (en) Dental compositions
AU4318000A (en) Agarobiose-containing composition
AU3192700A (en) Medicinal compositions
AU4541800A (en) Organosiloxane compositions
AU3556400A (en) Pharmaceutical compositions
AU1290501A (en) Composition
AU2005300A (en) Medicinal compositions
AU1530001A (en) Inhibitor compositions
AU7025300A (en) Nutritional compositions
AU1072801A (en) Gel-forming compositions
AU6460400A (en) Pharmaceutical compositions
AU2681500A (en) Rapidly-soluble compositions
AUPQ197899A0 (en) Biomedical compositions
AU4800800A (en) Fuel compositions
AU1152601A (en) Compositions and their use
AU5085300A (en) Compositions
AU2844801A (en) Fuel compositions
AU6460200A (en) Pharmaceutical compositions
AU6310600A (en) Composition
AU6217199A (en) Compositions
AU7857600A (en) Conductor composition
AU6460100A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase